It sure has promise, however, as ohm has already pointed out somewhere, it seems they are trying to cherry-pick patients in their trial, which is ridiculous

EXLUSION CRITERIA

[...]

"ANY condition that, in the opinion of the investigator, is likely to interfere with the safety and EFFICACY of the study treatment or puts the patient at unacceptably high risk from the study".